|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.64 USD | +2.20% |
|
+1.73% | - |
| 10/06 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| 09/06 | Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment | MT |
| Market Cap | 198.19Cr 171.99Cr 158.54Cr 148.55Cr 277.56Cr 19TCr 283.34Cr 1.89TCr 732.21Cr 9.15TCr 744.02Cr 727.99Cr 32TCr | P/E Ratio 2026 * |
-7.97x | P/E Ratio 2027 * | -9.46x |
|---|---|---|---|---|---|
| Enterprise Value | 153.88Cr 133.54Cr 123.09Cr 115.34Cr 215.5Cr 15TCr 219.99Cr 1.47TCr 568.5Cr 7.1TCr 577.67Cr 565.22Cr 25TCr | EV / Sales 2026 * |
3.43x | EV / Sales 2027 * | 2.68x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | +2.20% | ||
| 1 week | +1.73% | ||
| Current month | -0.28% | ||
| 1 month | -9.95% | ||
| 3 months | -7.50% | ||
| 6 months | -1.01% |
| 1 week | 16.26 | 17.91 | |
| 1 month | 16.26 | 21.33 | |
| Current year | 15.96 | 25.28 | |
| 1 year | 15.96 | 42 | |
| 3 years | 13.48 | 44.34 | |
| 5 years | 13.48 | 178.91 | |
| 10 years | 13.48 | 193.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 60 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 60 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 82 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 74 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.20% | +1.73% | -57.39% | -37.36% | 193.92Cr | ||
| +1.63% | -2.74% | +17.91% | -18.09% | 6.12TCr | ||
| +2.50% | +4.43% | +64.44% | +216.37% | 5.82TCr | ||
| -0.92% | +28.60% | +28.60% | +28.60% | 3.95TCr | ||
| +1.31% | +17.46% | -54.84% | -64.75% | 3.51TCr | ||
| +2.94% | +1.79% | +50.28% | -35.26% | 2.87TCr | ||
| +2.32% | +6.51% | +56.62% | +76.65% | 2.11TCr | ||
| +7.94% | -3.78% | +78.88% | -59.73% | 1.82TCr | ||
| -1.88% | -5.07% | -10.05% | +93.76% | 1.65TCr | ||
| +0.78% | +0.78% | +49.83% | +98.01% | 1.59TCr | ||
| Average | +1.89% | +1.18% | +22.43% | +29.82% | 2.96TCr | |
| Weighted average by Cap. | +1.76% | +1.43% | +29.16% | +43.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 39Cr 36Cr 34Cr 63Cr 4.3TCr 64Cr 428.15Cr 165.77Cr 2.07TCr 168.44Cr 164.81Cr 7.2TCr | 60Cr 52Cr 48Cr 45Cr 83Cr 5.7TCr 85Cr 568.31Cr 220.03Cr 2.75TCr 223.58Cr 218.76Cr 9.56TCr |
| Net income | -24Cr -21Cr -19Cr -18Cr -34Cr -2.31TCr -34Cr -229.87Cr -89Cr -1.11TCr -90Cr -88Cr -3.87TCr | -16Cr -14Cr -13Cr -12Cr -22Cr -1.5TCr -22Cr -149.31Cr -58Cr -722.19Cr -59Cr -57Cr -2.51TCr |
| Net Debt | -44Cr -38Cr -35Cr -33Cr -62Cr -4.24TCr -63Cr -422.84Cr -163.71Cr -2.05TCr -166.35Cr -162.77Cr -7.11TCr | -39Cr -34Cr -31Cr -29Cr -54Cr -3.71TCr -55Cr -369.46Cr -143.04Cr -1.79TCr -145.35Cr -142.22Cr -6.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 17.64 $ | +2.20% | 10,05,002 |
| 10/26/10 | 17.26 $ | +3.66% | 11,71,343 |
| 09/26/09 | 16.65 $ | +1.03% | 13,80,829 |
| 08/26/08 | 16.48 $ | -0.84% | 10,84,399 |
| 05/26/05 | 16.62 $ | -4.15% | 16,94,996 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















